Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia

NCT02675049 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia

Interventions

DRUG: 0.9% saline
DRUG: dexmedetomidine 1µg.kg-1
DRUG: dexmedetomidine 1.5µg.kg-1
DRUG: Dexmedetomidine 2µg.kg-1

Sponsor

Tianjin Medical University Cancer Institute and Hospital